Ítem
Acceso Abierto

Influence of Artificial Intelligence in the firm outcomes by the innovation and R&D perspective

Mostrar el registro sencillo de la publicación
dc.contributor.advisorMazloomi Khamseh, Hamid
dc.creatorArciniegas Jiménez, Ana María
dc.creator.degreeAdministrador de Negocios Internacionales
dc.creator.degreetypeFull time
dc.date.accessioned2021-02-16T17:55:06Z
dc.date.available2021-02-16T17:55:06Z
dc.date.created2019-10-28
dc.descriptionEl objetivo principal de esta tesis es analizar y evaluar la complejidad de la cultura de la empresa que debido a los nuevos entornos empresariales y las nuevas dinámicas internas de trabajo ha cambiado de diversas formas. Esta tesis examina el papel de la inteligencia artificial en las organizaciones y la forma en que influye en la innovación y la I + D. Además, este proyecto evalúa y analiza los retos a los que se enfrentan las empresas para optimizar sus recursos, incrementar la innovación, incorporar la I + D en función del tamaño, la cultura corporativa y el presupuesto disponible que debido a los nuevos entornos de negocio y las nuevas dinámicas internas de trabajo ha tenido que cambiar considerablemente. Además, analiza la tendencia de los nuevos usos de las redes neuronales artificiales para analizar datos y como nueva herramienta para desarrollar en profundidad la IA en las empresas. En esta investigación, voy a seleccionar la Industria Farmacéutica, para analizarla. Además, esta visión identificará la relación proporcional de los instrumentos de IA y los crecientes resultados. Por otro lado, este estudio quiere proponer una nueva forma de cómo la IA puede cambiar las organizaciones en un contexto corporativo, mediante el uso de la innovación y su aplicación en todo el proceso de I + D. Sabiendo esto, el enfoque propuesto quiere comprender los componentes más importantes de la toma de decisiones de la empresa utilizando nuevas tecnologías, como la IA.spa
dc.description.abstractThe main purpose of this thesis is to analyze and evaluate the company culture complexity which due to the new business environments and the new internal work dynamics has changed in several ways. This thesis examines the role of Artificial Intelligence in the organizations and the way it influences innovation and R&D. Moreover, this project evaluates and analyze the challenges, which the companies are facing to optimize their resources, increment innovation, incorporate R&D depending on the size, corporate culture and available budget that due to the new business environments and the new internal dynamics to work has changed considerably. Furthermore, it analyzes the tendency of the new uses of artificial neural networks to analyze data and as a new tool to develop in-depth the AI in the companies. In this research, I am going to select a specific industry to be analyzed, the Pharmaceutical Industry. This paper will reach all the processes from the R&D and innovation area of the companies that AI affect. In addition, this vision will identify the proportional relation of AI instruments and the increasing outcomes. On the other hand, this study wants to purpose a new way of how AI can change organizations in a corporate context, through the usage of innovation and the application of it in the whole process of R&D. Knowing this, the proposed approach wants to understand the most important components of company decision making using new technologies, such as AI.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.48713/10336_30917
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/30917
dc.language.isoeng
dc.publisherUniversidad del Rosario
dc.publisher.departmentEscuela de Administración
dc.publisher.programAdministración de Negocios Internacionales
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombiaspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.source.bibliographicCitationRomeo, L., Loncarski, J., Paolanti, M., Bocchini, G., Mancini, A., & Frontoni, E. (2020). Machine learning-based design support system for the prediction of heterogeneous machine parameters in industry 4.0. Expert Systems With Applications, 140. https://doi-org.ez.urosario.edu.co/10.1016/j.eswa.2019.112869
dc.source.bibliographicCitationFast, N. J., & Schroeder, J. (2020). Power and decision making: new directions for research in the age of artificial intelligence. Current opinion in psychology, 33, 172–176. https://doi.org/10.1016/j.copsyc.2019.07.039
dc.source.bibliographicCitationCampus, A. (2019). Corporate Financial Evaluation and Bankruptcy Prediction Implementing Artificial Intelligence Methods. Retrieved from: http://www.wseas.us/e-library/conferences/2006cscc/papers/534-877.pdf [Accessed 26 Sept. 2019].
dc.source.bibliographicCitationGriliches, Z. (1984). R&D and Innovation: Some Empirical Findings. Retrieved from: https://www.nber.org/chapters/c10047.pdf
dc.source.bibliographicCitationHameed, Farhan, Iqbal, W. (2018). Determinants of Firm’s open innovation performance and the role of R & D department: an empirical evidence from Malaysian SME’s. Retrieved from: https://journal-jger.springeropen.com/track/pdf/10.1186/s40497-018-0112-8
dc.source.bibliographicCitationXiuqin Li, Dimitri Gagliardi & Ian Miles (2019) Innovation in R&D service firms: evidence from the UK, Technology Analysis & Strategic Management, 31:6, 732-748, DOI: 10.1080/09537325.2018.1549729
dc.source.bibliographicCitationSiraj, Hussain, F. (2008). ARTIFICIAL INTELLIGENCE IN MEDICAL APPLICATION: AN EXPLORATION. Retrieved from: https://www.researchgate.net/profile/Wan_Hussain_Wan_Ishak/publication/240943548_ARTIFICIAL_INTELLIGENCE_IN_MEDICAL_APPLICATION_AN_EXPLORATION/links/00b7d5292d45d674ab000000.pdf
dc.source.bibliographicCitationTull, E. Miller, S. (2019). The Journal of Robotics, Artificial Intelligence & Law. Retrieved from: https://www.finnegan.com/images/content/1/9/v2/197825/PUBLISHED-The-Journal-of-Robotics-Artificial-Intelligence-L.pdf
dc.source.bibliographicCitationLi, Gagliardi, Miles, X. (2018). Innovation in R&D service firms: evidence from the UK. Retrieved from: https://www-tandfonline-com.ez.urosario.edu.co/doi/full/10.1080/09537325.2018.1549729
dc.source.bibliographicCitationRamesh, Kambhampati, Monson, A. (2004). Artificial intelligence in medicine. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964229/pdf/15333167.pdf
dc.source.bibliographicCitationKatherine Wolf, Nakia Woodward & Richard Wallace (2013) ClinicalKey: A Review, Journal of Electronic Resources in Medical Libraries, 10:2, 79-87, DOI: 10.1080/15424065.2013.792592
dc.source.bibliographicCitationAlexander, A., McGill, M., Tarasova, A., Ferreira, C. and Zurkiya, D. (2019). Scanning the Future of Medical Imaging. Retrieved from: https://www-clinicalkey-es.ez.urosario.edu.co/#!/content/playContent/1-s2.0S1546144018312821?returnurl=null&referrer=null
dc.source.bibliographicCitationHengstler, M., Enkel, E. and Duelli, S. (2016). Applied artificial intelligence and trust—The case of autonomous vehicles and medical assistance devices. Retrieved from: https://www-sciencedirect-com.ez.urosario.edu.co/science/article/pii/S0040162515004187
dc.source.bibliographicCitationImpedovo, D. and Pirlo, G. (2019). eHealth and Artificial Intelligence. Retrieved from: http://file:///C:/Users/anama/Downloads/eHealth-and-artificial-intelligence2019Information-SwitzerlandOpen-Access.pdf
dc.source.bibliographicCitationTsang, L., Kracov, D., Mulryne, J., Strom, L., Perkins, N., Dickinson, R., Wallace, V. and Jones, B. (2019). The Impact of Artificial Intelligence on Medical Innovation in the European Union and United States. Retrieved from: https://www.arnoldporter.com/-/media/files/perspectives/publications/2017/08/the-impact-of-artificial-inteelligence-on-medical-innovation.pdf
dc.source.bibliographicCitationMateos-Garcia, J. (2018). The Complex Economics of Artificial Intelligence. Retrieved from: https://www.nesta.org.uk/blog/complex-economics-artificial-intelligence/
dc.source.bibliographicCitationFast, N. and Schroeder, J. (2019). Power and decision making: new directions for research in the age of artificial intelligence. Retrieved from: http://file:///C:/Users/anama/Downloads/Power-and-decision-making-new-directions-for-research-in-the-age-of-artificial-intelligence2020Current-Opinion-in-Psychology.pdf.
dc.source.bibliographicCitationNogueira, R., Pini, F., Otávio, M. and Lúcia Chicarelli, R. (2014). Analyzing effects of external integration on innovations outcomes in large and non-large Brazilian food companies. Retrieved from: https://www.researchgate.net/publication/263287843_Analyzing_effects_of_external_integration_on_innovations_outcomes_in_large_and_non-large_Brazilian_food_companies
dc.source.bibliographicCitationLevy, S. (2018) ‘Intelligent Business: Pharmacy software companies look to enable better outcomes, clinical interventions’, Drug Store News, 40(11), p. 38. Retrieved from: http://search.ebscohost.com.ez.urosario.edu.co/login.aspx?direct=true&db=f5h&AN=132843977&lang=es&site=eds-live&scope=site.
dc.source.bibliographicCitationJespersen, K. R. (2018). Crowdsourcing design decisions for optimal integration into the company innovation system. Decision Support Systems, 115, 52–63. https://doi-org.ez.urosario.edu.co/10.1016/j.dss.2018.09.005
dc.source.bibliographicCitationHengstler, M., Enkel, E. and Duelli, S. (2019). Applied artificial intelligence and trust—The case of autonomous vehicles and medical assistance devices. Retrieved from: https://www-sciencedirect-com.ez.urosario.edu.co/science/article/pii/S0040162515004187
dc.source.bibliographicCitationTsang, L., Kracov, D., Mulryne, J., Strom, L., Perkins, N., Dickinson, R., Wallace, V. and Jones, B. (2019). The Impact of Artificial Intelligence on Medical Innovation in the European Union and United States. Retrieved from: https://www.arnoldporter.com/~/media/files/perspectives/publications/2017/08/the-impact-of-artificial-inteelligence-on-medical-innovation.pdf
dc.source.bibliographicCitationLichtenthaler, U. (2020), "Beyond artificial intelligence: why companies need to go the extra step", Journal of Business Strategy, Vol. 41 No. 1, pp. 19-26. https://doi.org/10.1108/JBS-05-2018-0086
dc.source.bibliographicCitationJean Paul Simon, author (2019) ‘Artificial intelligence: scope, players, markets and geography’, Digital Policy, Regulation and Governance, (3), p. 208. doi: 10.1108/DPRG-08-2018-0039.
dc.source.bibliographicCitationAgrawal, A., Gans, J. and Goldfarb, A. (2019). What to Expect From Artificial Intelligence. Retrieved from: https://sloanreview.mit.edu/article/what-to-expect-from-artificial-intelligence/
dc.source.bibliographicCitationYamakawa, P. and Ostos, J. (2011). Relación entre innovación organizacional y desempeño organizacional. Retrieved from: https://revistas.urosario.edu.co/index.php/empresa/article/view/1889
dc.source.bibliographicCitationAmato, F. et al. (no date) ‘Chatbots meet ehealth: Automatizing healthcare’, CEUR Workshop Proceedings, 1982, pp. 40–49. Retrieved from: http://search.ebscohost.com.ez.urosario.edu.co/login.aspx?direct=true&db=edselc&AN=edselc.2-52.0-85034835878&lang=es&site=eds-live&scope=site
dc.source.bibliographicCitationMansury, M. A., & Love, J. H. (2008). Innovation, productivity and growth in US business services: A firm-level analysis. Technovation, 28(1), 52–62. https://doi-org.ez.urosario.edu.co/10.1016/j.technovation.2007.06.002
dc.source.bibliographicCitationKlinger, J., Mateos-Garcia, J. and Stathoulopoulos, K. (2018). Deep Learning, Deep Change? Mapping the Development of the Artificial Intelligence General Purpose Technology. SSRN Electronic Journal.
dc.source.bibliographicCitationMateos-García, J. (2018). The Complex Economics of Artificial Intelligence. Nesta. Retrieved from: https://www.nesta.org.uk/blog/complex-economics-artificial-intelligence/
dc.source.bibliographicCitationKazuyuki, M. (2018). Understanding AI Driven Innovation by Linked Database of Scientific Articles and Patents. RIETI Policy Discussion Paper Series 18-P-017. Retrieved from: https://www.rieti.go.jp/jp/publications/pdp/18p017.pdf
dc.source.bibliographicCitationGuellec, D., Paunov, C., (2018). Innovation Policies in the Digital Age. OECD publishing No.59. Retrieved from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=DSTI/STP/TIP(2018)5/FINAL&docLanguage=En
dc.source.bibliographicCitationShahid, N., Rappon, T., & Berta, W. (2019). Applications of artificial neural networks in health care organizational decision-making: A scoping review. PLoS ONE, 14(2), 1–22. https://doi-org.ez.urosario.edu.co/10.1371/journal.pone.0212356
dc.source.bibliographicCitationMoshe A. Barach, Aseem Kaul, Ming D. Leung, & Sibo Lu. (2019). Strategic Redundancy in the Use of Big Data: Evidence from a Two-Sided Labor Market. Strategy Science, 4, 298. https://doi-org.ez.urosario.edu.co/10.1287/stsc.2019.0093.
dc.source.bibliographicCitationTing, K., Lee, R., Milne, G., Shapiro, M. and Guarino, A. (1973). Applications of Artificial Intelligence: Relationships between Mass Spectra and Pharmacological Activity of Drugs. Science, 180(4084), pp.417-420.
dc.source.bibliographicCitationNamaki, M. S. S. E. (2018). How Companies are Applying AI to the Business Strategy Formulation. Scholedge International Journal of Business Policy & Governance, 5(8), 77–82. https://doi-org.ez.urosario.edu.co/10.19085/journal.sijbpg050801
dc.source.bibliographicCitationStudy Data from University of Vaasa Provide New Insights into Industrial Change (Internationalization of corporate R&D activities and innovation performance). (2017, March 4). Investment Weekly News, 792.
dc.source.bibliographicCitationNadia Ayari. (2010). Internal Capabilities, R&D Cooperation with Universities and Firms Innovativeness Level: Evidence from Spain. Faculty Working Papers.
dc.source.bibliographicCitationCockburn, Iain.., Henderson, Rebecca., Stern, Scott. (2017). The impact of Artificial Intelligence on Innovation. Retrieved from: https://www.nber.org/chapters/c14006.pdf
dc.source.bibliographicCitationRay, Tiernan. (2019). Finding New Cures in Old Drugs. ISSN: 0015-8259. Retrieved From: Fortune. 4/1/2019, Vol. 179 Issue 4, p74-79. 6p. 2 Color Photographs, 1 Diagram.
dc.source.bibliographicCitationLichtenthaler, U. (2018). The world’s most innovative companies: a meta-ranking | Emerald Insight. [online] Emerald.com. Retrieved from: https://www.emerald.com/insight/content/doi/10.1108/JSMA-07-2018-0065/full/html
dc.source.bibliographicCitationSong, J. and Zhang, Z. (2019). A Modified Robust FCM Model with Spatial Constraints for Brain MR Image Segmentation. Retrieved from: https://www.mdpi.com/2078-2489/10/2/74/pdf
dc.source.bibliographicCitationDemirdogen, G., & Isik, Z. (2016). Effect of internal capabilities on success of construction company innovation and technology transfer/Ucinak vlastitog potencijala na uspjesnost inovacija i prijenosa tehnologije u gradevinskom poduzecu. Tehnicki Vjesnik - Technical Gazette, 6, 1763. https://doi-org.ez.urosario.edu.co/10.17559/TV-20151222154916
dc.source.bibliographicCitationHsu, C.-L., Tseng, K. C., & Chuang, Y.-H. (2012). A secure IRB system for assisting the development of intelligent medical devices. Expert Systems With Applications, 39(16), 12512–12521. https://doi-org.ez.urosario.edu.co/10.1016/j.eswa.2012.04.062
dc.source.bibliographicCitationGilvary, C., Madhukar, N., Elkhader, J., & Elemento, O. (2019). The Missing Pieces of Artificial Intelligence in Medicine. Trends in Pharmacological Sciences, 40(8), 555–564. https://doi-org.ez.urosario.edu.co/10.1016/j.tips.2019.06.001
dc.source.bibliographicCitationHsu, C.-L., Tseng, K. C., & Chuang, Y.-H. (2012). A secure IRB system for assisting the development of intelligent medical devices. Expert Systems With Applications, 39(16), 12512–12521. https://doi-org.ez.urosario.edu.co/10.1016/j.eswa.2012.04.062
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR
dc.subjectInteligencia Artificialspa
dc.subjectAprendizaje automatizadospa
dc.subjectRedes neuronalesspa
dc.subjectIndustria Farmacéuticaspa
dc.subjectInvestigación y Desarrollospa
dc.subjectInnovaciónspa
dc.subjectTendencias del Futurospa
dc.subjectSistemas Inteligentesspa
dc.subject.keywordArtificial Intelligencespa
dc.subject.keywordMachine Learningeng
dc.subject.keywordNeural Networkseng
dc.subject.keywordPharmaceutical Industryeng
dc.subject.keywordR&Deng
dc.subject.keywordInnovationeng
dc.subject.keywordFuture Trendseng
dc.subject.keywordDrug discoveryeng
dc.subject.keywordIntelligent systemseng
dc.subject.keywordFirm outcomeseng
dc.titleInfluence of Artificial Intelligence in the firm outcomes by the innovation and R&D perspectiveeng
dc.title.alternativeInfluence of Artificial Intelligence in the firm outcomes by the innovation and R&D perspectivespa
dc.typebachelorThesiseng
dc.type.documentTrabajo de gradospa
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.type.spaTrabajo de gradospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
Arciniegas.Jimenez-AnaMaria-2021.pdf
Tamaño:
581.96 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Pregrado en Administración de Negocios Internacionales